Reported 3 days ago
Despite a frothy stock market, there are still worthwhile investments to consider before the end of 2024. BioNTech, with its promising cancer therapies in late-stage testing, and Vertex Pharmaceuticals, anticipating FDA approvals for innovative treatments soon, stand out as strong options for investors looking for growth opportunities.
Source: YAHOO